pulmonary hypertension

March 23, 2015November 5, 2015

Long-term Data on Selexipag for PAH Presented at American College of Cardiology (ACC) 2015

Actelion Ltd recently presented long-term results at the American College of Cardiology (ACC) Congress in San Diego, US from their pivotal selexipag (Uptravi®) Phase III GRIPHON trial. The company reported that, ... Read more

March 19, 2015November 5, 2015

Computed Tomography Pulmonary Angiography Measurements Shown as a Predictive Tool for Pulmonary Hypertension

News, Pulmonary Hypertension

Researchers at the VU University Medical Center in Amsterdam, The Netherlands recently published findings in The International Journal of Cardiovascular Imaging that reveal specific measurements obtained by standard computed tomography ... Read more

March 16, 2015March 16, 2015

COPD Patients with Pulmonary Hypertension are More Prone to Co-Morbidities

News

Researchers at the Cairo University in Egypt recently reported that patients with chronic obstructive pulmonary disease (COPD) can also develop co-morbidities as pulmonary hypertension and cardiac alterations. The study was ... Read more

March 6, 2015March 6, 2015

PH Due to Langerhans Cell Histiocytosis May Benefit from Common PH Therapy, Case Study Shows

News

Researchers at the Mayo Clinic, Rochester, MN, published a clinical case study in which a novel therapeutic approach showed promising results in treating a fairly uncommon lung disease, known as ... Read more

March 2, 2015November 9, 2015

Enhancing and Inhibiting Autophagy in Lung Disease is Double-Edged

COPD, News

Researchers from the Weill Cornell Medical College and New York-Presbyterian Hospital in New York recently discussed the role of autophagy in lung diseases in a study titled “Autophagy in lung disease pathogenesis ... Read more

December 2, 2014December 2, 2014

Therapeutic Peptide Can Protect Against PH-Induced Cardiac Failure

News

RegeneRx Biopharmaceuticals, Inc., a company specializing in the development of a groundbreaking therapeutic peptide called thymosin beta 4 (TB4) for tissue and organ protection, repair and regeneration, has just published new research ... Read more

November 21, 2014November 5, 2015

Photo Contest Launched on First Annual CTEPH Awareness Day by Bayer

News, Pulmonary Hypertension

Bayer HealthCare Pharmaceuticals is launching an awareness and patient support campaign to support those suffering from chronic thromboembolic pulmonary hypertension (CTEPH), a type of pulmonary hypertension (PH) that provokes blood clots in the ... Read more